fbpx

The Digest

Pharma news roundup and Larvol updates

Contact Us
Category: COVID-19 News

COVID-19 | List of Cancelled & Rescheduled Conferences 2020

April 2, 2020

Click here to download the full list. No signup necessary.

 

Over 230 healthcare and pharma conferences have changed or cancelled their upcoming meetings because of COVID-19. Here is an updated list on the current status of these conferences.

 

Last Updated: April 2, 2020

 

 

Acronym Conference Status Comments Abstracts Status
ECFS 2020 43rd European Cystic Fibrosis Conference TENTATIVE Decision about the congress is on hold Preliminary program available
SPINE SUMMIT 2020 36th Annual Meeting of the Section on Disorders of the Spine and Peripheral Nerves TENTATIVE Decision about the congress is on hold Preliminary program available
AACR 2020 American Association of Cancer Research Annual Meeting POSTPONED Exact date and location TBD Preliminary program available
AACRPRCA 2020 Advances in Prostate Cancer Research 2020 POSTPONED Exact date and location TBD Preliminary program available
AASLD-INASL 2020 AASLD-INASL Connect Program 2020 POSTPONED Postponed until August 2020, India Preliminary program available
ACMG 2020 2020 ACMG Annual Clinical Genetics Meeting POSTPONED Postponed until early May 2020. Looking for digital edition Preliminary program available
ACTHIV 2020 14th Annual American Conference for the Treatment of HIV 2020 POSTPONED Postponed until August 20-22, 2020, Chicago, IL, USA Preliminary program available
ADCM 2020 4th World Congress on Advances in Diabetes Care and Metabolism POSTPONED Postponed until May 25-25, 2020, Dublin, Ireland No information available
ADI 2020 34th International Conference of Alzheimer’s Disease International POSTPONED Postponed until December 10-12, 2020, Singapore Preliminary program available
ALPHA 2020 13th Biennial Alpha Conference POSTPONED Postponed until October 29-November 01, 2020, Sevilla, Spain Preliminary program available
ANPA 2020 31st Annual Meeting of the American Neuropsychiatric Association POSTPONED Postponed until  March 17-20, 2021, Boston, MA Preliminary program available
ANZAC 2020 6th Australian and New Zealand Addiction Conference POSTPONED Postponed until Dec 07-09, 2020, Gold Coast Abstracts available
APAO 2020 35th Asia-Pacific Academy of Ophthalmology Congress POSTPONED Postponed until August 5-9, 2020, Xiamen, China No information available
APBCS 2020 9th Asia Pacific Breast Cancer Summit POSTPONED Exact date and location TBD No information available
APCM 2020 54th Annual Pancreas Club Meeting POSTPONED Exact date and location TBD No information available
APGCS 2020 7th Asia Pacific Gastroenterology Cancer Summit POSTPONED Exact date and location TBD No information available
APS EB 2020 APS Annual Meeting at Experimental Biology POSTPONED Postponed until May 1-4 , 2021, Indianapolis, IN, USA Preliminary program available
ASIP 2020 Annual Meeting of American Society for Investigative Pathology POSTPONED Postponed until May 1-4 , 2021, Indianapolis, IN, USA Preliminary program available
ASPIRE 2020 10th Asia Pacific Initiative of Reproduction Congress POSTPONED Postponed until August 04-07, 2020, Manila, Philippines Preliminary program available
AUTO 2020 12th International Congress on Autoimmunity POSTPONED Postponed until November 28- December 01, 2020, Athens No information available
AVS 2020 11th Annual Venous Symposium POSTPONED Postponed until July 30-August 1, 2020 Preliminary program available
BIOS 2020 18th Annual Biosimilar Medicines Conference POSTPONED Postponed until September 17-18, 2020, Amsterdam, Netherlands No information available
BPS 2020 53rd Annual Scientific Meeting of the British Pain Society POSTPONED Exact date and location TBD Titles available
BRAVS 2020 45th Congress of the Brazilian Retina and Vitreous Society POSTPONED Exact date and location TBD Preliminary program available
BTEC 2020 BTEC 2020 Annual Meeting POSTPONED Exact date and location TBD Preliminary program available
Cardiologists 2020 32nd Annual Cardiologists Conference POSTPONED Postponed until August 24-25, 2020, Edinburgh, Scotland No information available
CCF 2020 2020 Cholangiocarcinoma Foundation Annual Conference POSTPONED Postponed until later this year Preliminary program available
CDNATL 2020 Cardiology, Diabetes & Nephrology At the Limits 2020 POSTPONED Postponed until October 31-November 1, 2020 Preliminary program available
CFA 2020 15th Francophone Congress of Allergology POSTPONED Postponed until July 7-10, 2020 Preliminary program available
CMHC-WEST 2020 The Annual Cardiometabolic Health Congress West 2020 POSTPONED Postponed until August 07-09, 2020, Scottsdale Preliminary program available
CONy 2020 14th World Congress on Controversies in Neurology POSTPONED Postponed until October 02-05, 2020, London Preliminary program available
COPHy AA 2020 6th Annual Congress on Controversies in Ophthalmology: Asia-Australia POSTPONED Postponed until 2021. Exact date and location TBD Abstracts available
DECON 2020 6th International Diabetes and Endocrine Conference POSTPONED Postponed until August 29-30, 2020 No information available
DGAUM 2020 60th Annual Meeting of the DGAUM POSTPONED Postponed until September 02-05, 2020, Munich, Germany Abstracts available
DGP 2020 61st Congress of the German Society of Pneumology and Respiratory Medicine POSTPONED Postponed until June 24-27, 2020 Titles available
DNS 2020 Danish Nephrological Society’s Annual Meeting POSTPONED Postponed until October 02, 2020, Odense, Denmark No information available
EADO 2020 16th European Association of Dermato-Oncology Congress POSTPONED Postponed until October 12-14, 2020 Preliminary program available
EAO-CRC 2020 6th Annual Early Age Onset Colorectal Cancer Summit POSTPONED Exact date and location TBD Preliminary program available
EAS 2020 88th European Atherosclerosis Society Congress POSTPONED Postponed until October 4-7, 2020 Preliminary program available
EASL-ILC 2020 International Liver Congress of the European Association for the Study of the Liver POSTPONED Postponed until August 25-28, 2020 Abstracts available
EAU 2020 35th Annual European Association of Urology Congress POSTPONED Postponed until July 17-21, 2020 Titles available
EBCC 2020 12th European Breast Cancer Conference POSTPONED Postponed until September 30-October 2, 2020, Barcelona, Spain Titles available
EBMT 2020 46th Annual Meeting of the European Group for Bone and Marrow Transplantation POSTPONED Postponed until August 30-September 2, 2020, Madrid, Spain Abstracts available
ECIO 2020 European Conference on Interventional Oncology POSTPONED Postponed until November 02-05, 2020, Nice, France Preliminary program available
EDEG 2020 European Diabetes and Epidemiology Group Annual Meeting POSTPONED Postponed until April 24-27, 2021 No information available
EFI 2020 34th European Immunogenetics and Histocompatibility Conference POSTPONED Exact date and location TBD Preliminary program available
EGS 2020 14th European Glaucoma Society Congress POSTPONED Postponed until December 14-16, 2020 No information available
EGVRS 2020 18th International Egyptian Vitreoretinal Society Annual Meeting POSTPONED Postponed until November 25-27, 2020 No information available
EHC-UAE 2020 10th Emirates Haematology Conference POSTPONED Exact date and location TBD Preliminary program available
Elevate 2020 Elevate by Psych Congress POSTPONED Postponed until July 25–27, 2020 Preliminary program available
EMIM 2020 15th European Molecular Imaging Meeting POSTPONED Postponed until August 25-28, 2020, Thessaloniki, Greece Preliminary program available
EPA 2020 28th European Congress of Psychiatry POSTPONED Postponed until July 04-07, 2020, Madrid Abstracts available
EPIC-SEC 2020 The Emory Practical Intervention Course-Southeast Consortium POSTPONED Postponed until August 27-29, 2020 No information available
EPOMEC 2020 7th Evolving Practice of Ophthalmology Middle East Conference POSTPONED Postponed until December 10-12, 2020, Dubai, UAE No information available
ESA 2020 27th Annual meeting of the European Surgical Association POSTPONED Exact date and location TBD No information available
ESCRH 2020 16th Congress of The European Society of Contraception and Reproductive Health POSTPONED Exact date and location TBD No information available
ESGO 2020 4th State of the Art Conference of the European Society of Gynaecological Oncology POSTPONED Postponed until December 14-16, 2020 No information available
ESH-ICMDS 2020 ESH-7th International Conference on Myelodysplatic Syndromes POSTPONED Postponed until January 28-30, 2021 No information available
ESO-WSO 2020 Joint European Stroke Organisation and World Stroke Organisation Conference POSTPONED Postponed until November 07-09, 2020, Vienna Preliminary program available
ESTRO 2020 39th Conference of the European Society for Radiotherapy & Oncology POSTPONED Postponed until July 31-Aug 4, 2020 Abstracts available
EuroELSO 2020 9th EuroELSO Congress POSTPONED Postponed until March 29-31, 2021 Preliminary program available
Fibromyalgia 2020 The 2nd International Congress on Controversies in Fibromyalgia POSTPONED Exact date and location TBD Preliminary program available
FLASCO-Spring 2020 2020 FLASCO Spring Session with Business of Oncology Summit FLASCO-Spring POSTPONED Postponed until October 30-31, 2020, Orlando, FL, USA No information available
FOKO 2020 FOKO Training Conference POSTPONED Postponed until March 3-6, 2021, Dusseldorf, Germany Preliminary program available
GALA-Dallas 2020 GI And Liver Association Of The Americas-7th Annual Dallas Conference POSTPONED Exact date and location TBD Preliminary program available
GAPNA-Pharmacology 2020 GAPNA Contemporary Pharmacology and Prescribing in Older Adults Conference POSTPONED Postponed until  April 20-14, 2021, Honolulu, HI, USA Preliminary program available
GBCC 2020 Global Breast Cancer Conference 2020 POSTPONED Postponed until April 08 – 10, 2021 Preliminary program available
GDU GI 2020 Great Debates and Updates in Gastrointestinal Malignancies POSTPONED Postponed until August 13-15, 2020, New York Preliminary program available
GTC 2020 Gulf Thoracic Congress POSTPONED Exact date and location TBD Titles available
GUE 2020 7th Gastro Update Europe POSTPONED Postponed until September 4-5,2020, Bratislava Preliminary program available
HFA 2020 Annual Symposium of the Hemophilia Federation of America POSTPONED Postponed until August 24-26, 2020, Baltimore No information available
HIV-HEP 2020 HIV & Hepatitis in the Americas 2020 POSTPONED Postponed until October 29-31, 2020 Preliminary program available
ICCN 2020 International Conference on Cancer Nursing POSTPONED Postponed until March 2021. Exact date and location TBD Preliminary program available
ICHS 2020 21st ICHS Symposium on Infections in the Immunocompromised Host POSTPONED Postponed until January 31-02, 2021, Melbourne No information available
ICID 2020 19th International Congress On Infectious Diseases POSTPONED Postponed until September 10-13, 2020, Kuala Lumpur, Malaysia No information available
ICP-ISCAP 2020 12th International Congress on Psychopharmacology & 8th International Symposium on Child and Adolescent Psychopharmacology POSTPONED Postponed until November 25-28, 2020 No information available
ICST 2020 6th International Cancer Study & Therapy Conference POSTPONED Postponed until September 24-25, 2020, Orlando Titles available
ICTHIC 2020 10th International Conference on Thrombosis and Hemostasis Issues in Cancer POSTPONED Postponed until October 23-25, 2020, Bergamo, Italy Preliminary program available
IDEA 2020 IDEA CONGRESS 2020 POSTPONED Postponed until September 02-06, 2020, Istanbul Preliminary program available
IDS 2020 Immunology of Diabetes Society Congress POSTPONED Postponed until October 14-18, 2020 No information available
IHHN 2020 International Health Humanities Consortium Conference POSTPONED Exact date and location TBD No information available
IMS 2020 17th World Congress on Menopause POSTPONED Postponed until February 4-7, 2021 Preliminary program available
INA 2020 56th Annual Irish Neurological Association Meeting POSTPONED Exact date and location TBD No information available
INFARMA 2020 32nd European Pharmacies Conference and Medicine And Parapharmacy Exhibition-Infarma Madrid POSTPONED Postponed until June 30-July 2, 2020, Madrid, Spain No information available
IPPC 2020 International Plasma Protein Congress POSTPONED Postponed until October 01-02, 2020 Preliminary program available
IPVC 2020 33rd International Papillomavirus Conference POSTPONED Postponed until July 20-24, 2020 Titles available
ISAD 2020 11th Edition of Rajka International Symposium on Atopic Dermatitis POSTPONED Postponed until August 3-4, 2020, Seoul, South Korea No information available
ISGE 2020 19th World Congress of the International Society of Gynecological Endocrinology POSTPONED Postponed until December 2-5, 2020,Florence, Italy Abstracts available
ISLB 2020 ISLB 2020 Annual Meeting POSTPONED Postponed until October 30-31, 2020, Barcelona, Spain Preliminary program available
ISMRM 2020 28th Annual Meeting & Exhibition of International Society for Magnetic Resonance in Medicine POSTPONED Postponed until August 08-13, 2020, Paris, France Preliminary program available
ISOA 2020 XVII International Symposium on Amyloidosis POSTPONED Postponed until September 13-17, 2020, Tarragona, Spain Titles available
ISPSM 2020 4th International Live Operative Workshop, ESSO Certified, Advanced Course on Peritoneal Surface Malignancies, HIPEC & PIPAC POSTPONED Exact date and location TBD No information available
ITC 2020 2nd International Tremor Congress POSTPONED Exact date and location TBD Preliminary program available
ITOC 2020 7th Immunotherapy of Cancer Conference POSTPONED Postponed until October 3-5, 2020 Titles available
IUCLS 2020 17th International Ultmann Chicago Lymphoma Symposium POSTPONED Postponed until August 28-29, 2020 No information available
IVC 2020 18th International Vein Congress POSTPONED Postponed until July 09-11, 2020 Preliminary program available
JUA 2020 108th Annual Meeting of the Japanese Urological Association POSTPONED Postponed until July 23-26, 2020, Kobe, Japan No information available
Kiawah Eye 2020 Kiawah Eye Meeting 2020 POSTPONED Postponed until September 10-12, 2020, Kiawah Island Preliminary program available
KINGCA Week 2020 Korea International Gastric Cancer Week POSTPONED Postponed until August 3-5, 2020, Seoul, South Korea No information available
KKESH-SOS 2020 37th Annual Symposium of the King Khaled Eye Specialist Hospital and the 32nd Annual Scientific Meeting of the Saudi Ophthalmologic Society POSTPONED Exact date and location TBD No information available
KSN 2020 40th Annual Meeting of the Korean Society of Nephrology POSTPONED Postponed until September 24-27, 2020, Seoul Preliminary program available
MASCC-ISOO 2020 MASCC/ISOO Annual Meeting on Supportive Care in Cancer POSTPONED Postponed until June 24-26, 2021 Preliminary program available
MDA 2020 2020 Muscular Dystrophy Association Clinical and Research Conference POSTPONED Exact date and location TBD Abstracts available
MICNP 2020 MICNP’s 19th Annual Advanced Practice Nursing Conference POSTPONED Postponed until September 11-12, 2020 Preliminary program available
MI-Global 2020 The Milken Institute’s 23rd Global Conference POSTPONED Postponed until July 2020. Exact date and location TBD No information available
MTOS 2020 4th Miami Thyroid Oncology Symposium POSTPONED Postponed until November 13-14, 2020, North Miami, FL, USA Preliminary program available
NAA 2020 10th Annual Meeting of the North American Artery POSTPONED Postponed until May 2021 No information available
NASH-US 2020 4th Annual NASH Summit POSTPONED Postponed until December 15-18, 2020 Preliminary program available
NASPOG 2020 North American Society for Psychosocial Obstetrics and Gynecology Biennial Meeting POSTPONED Postponed until October 23-25, 2020 Preliminary program available
NCC 2020 Netherlands Contact Lens Congress POSTPONED Postponed until September 6-7, 2020 Titles available
NCCN 2020 NCCN 2020 Annual Conference POSTPONED Exact date and location TBD Preliminary program available
Neumomadrid 2020 XXV Congreso NEUMOMADRID POSTPONED Exact date and location TBD No information available
NEUROTALK 2020 BIT’s 11th Annual World Congress of Neurotalk POSTPONED Postponed until December 2-4, 2020, Singapore Preliminary program available
NGC 2020 7th International Conference on Nutrition and Growth POSTPONED Postponed until August 27-29, 2020 Abstracts available
NHMA 2020 2020 Hispanic Health Conference POSTPONED Postponed until March 18-21, 2021 Preliminary program available
NTNU 2020 3rd International NTNU Symposium on Clinical Biomarkers of Cancer POSTPONED Postponed until 2021. Exact date and location TBD Preliminary program available
PACD 2020 24th Pan Arab Conference on Diabetes POSTPONED Postponed until May 29-31, 2020 Preliminary program available
PCRS 2020 68th Annual Meeting of the Pacific Coast Reproductive Society POSTPONED Exact date and location TBD Preliminary program available
PreHT-HT-CMS 2020 7th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease POSTPONED Postponed until October 15-18, 2020, Vilnius, Lithuania No information available
PSM 2020 27th Regional Congress of the Perinatal Society of Malaysia POSTPONED Postponed until October 2020 Preliminary program available
RDDPDC 2020 Rheumatology Division Directors and Program Directors Conference POSTPONED Exact date and location TBD Preliminary program available
REG 2020 The 6th REG Summit POSTPONED Exact date and location TBD Preliminary program available
SAGES 2020 Society of American Gastrointestinal and Endoscopic Surgeons Annual Meeting POSTPONED Postponed until August 12-15, 2020 Preliminary program available
SED 2020 XXXI Congreso Nacional Sociedad Española de Diabetes POSTPONED Postponed until June 22-24, 2020, Madrid, Spain Preliminary program available
SGS 2020 46th Annual Meeting of Society of Gynecologic Surgeons POSTPONED Postponed until July 06-09, 2020 Preliminary program available
SICOA 2020 XVIII National Congress of Italian Society Cardiology Accredited Hospital POSTPONED Postponed until July 1-3, 2020, Naples Preliminary program available
Sleep Congress 2020 31st International Conference on Sleep Congress and Addiction POSTPONED Postponed until August 3-4,2020, Zurich, Switzerland No information available
SPMR 2020 8th Portuguese Congress of Reproductive Medicine POSTPONED Exact date and location TBD No information available
SSO 2020 Society of Surgical Oncology’s International Conference on Surgical Cancer Care POSTPONED Postponed until August 17-20,2020, Boston Abstracts available
SSRC 2020 7th Annual Conference of Saudi Society for Rheumatology POSTPONED Exact date and location TBD No information available
SSWC 2020 6th Systemic Sclerosis World Congress POSTPONED Postponed until July 12-14, 2020, Prague, Czech Republic Titles available
TEMHK 2020 42nd Turkey Endocrinology and Metabolic Diseases Congress POSTPONED Postponed until November 18-22, 2020, Antalya, Turkey Preliminary program available
THSNA 2020 5th Biennial Summit of the Thrombosis and Hemostasis Summit of North America POSTPONED Postponed until August 23-25, 2020, Chicago Titles available
UTHSCSA-CRC 2020 4th Annual Cardio Renal Connections Conference POSTPONED Exact date and location TBD No information available
WAEPS 2020 Washington Academy of Eye Physicians and Surgeons Annual Meeting POSTPONED Exact date and location TBD Preliminary program available
WCE 2020 14th World Congress on Endometriosis POSTPONED Postponed until September 11-14, 2020, Shanghai, China Preliminary program available
WCO-IOF-ESCEO 2020 World Congress On Osteoporosis, Osteoarthritis And Musculoskeletal Diseases POSTPONED Postponed until August 20-23, 2020, Barcelona, Spain Preliminary program available
WHCC 2020 17th Annual World Health Care Congress POSTPONED Postponed until August 2020 Preliminary program available
WIP 2020 10th biennial World Congress of The World Institute of Pain POSTPONED Postponed until August 26-29, 2020 Preliminary program available
WPW 2020 World Pharma Week 2020 POSTPONED Postponed until September 15-18, 2020, Boston Preliminary program available
AAAAI 2020 American Academy of Allergy, Asthma and Immunology Annual Meeting CANCELLED No further updates available Abstracts available
AACE 2020 American Association of Clinical Endocrinologists 29th Annual Scientific and Clinical Congress CANCELLED No further updates available Preliminary program available
AAD 2020 Annual Meeting of the American Academy of Dermatology CANCELLED No further updates available Preliminary program available
AAN 2020 72nd Annual Meeting of the American Academy of Neurology CANCELLED No further updates available Abstracts available
AANS 2020 88th Annual Scientific Meeting of American Association of Neurological Surgeons CANCELLED No further updates available Titles available
AAOS 2020 American Academy of Orthopaedic Surgeons Annual Meeting CANCELLED No further updates available Titles available
AAPOS 2020 46th Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus CANCELLED No further updates available Titles available
AASLDEASL-NAFLD 2020 AASLD/EASL NAFLD and NASH Clinical Endpoints Conference CANCELLED No further updates available Preliminary program available
AASLD-ETC 2020 AASLD-Emerging Topic Conference: Nuclear Receptors as Common Clinical Targets for the Treatment of Cholestatic and Nonalcoholic Fatty Liver Diseases CANCELLED No further updates available Preliminary program available
AATS 2020 100th Annual Meeting of American Association for Thoracic Surgery CANCELLED No further updates available Preliminary program available
ACOG 2020 69th ACOG Annual Clinical and Scientific Meeting CANCELLED No further updates available Preliminary program available
ACS-Sp 2020 259th ACS Spring National Meeting & Exposition CANCELLED No further updates available Abstracts available
ADAA 2020 40th Annual Anxiety and Depression Conference CANCELLED Next congress will be in March 18-21, 2021, Boston, MA, USA No information available
AFMR-ER 2020 AFMR-Eastern Regional Meeting CANCELLED No further updates available Preliminary program available
AGS-AM 2020 The American Geriatrics Society Annual Meeting CANCELLED No further updates available Preliminary program available
AMCP 2020 AMCP Managed Care & Specialty Pharmacy Annual Meeting CANCELLED Next congress will be in April 13-16, 2021, San Francisco, CA Abstracts available
ANZCA ASM 2020 2020 Annual Scientific Meeting of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine CANCELLED No further updates available Titles available
ANZSNM 2020 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine CANCELLED No further updates available Preliminary program available
AOTA 2020 American Occupational Therapy Association Annual Conference & Expo CANCELLED No further updates available Preliminary program available
APA 2020 American Psychiatric Association Annual Meeting CANCELLED No further updates available Preliminary program available
APhA AME 2020 American Pharmacists Association Annual Meeting & Exposition CANCELLED No further updates available Preliminary program available
APS 2020 40th Annual Scientific Meeting of Australian Pain Society CANCELLED No further updates available Titles available
ARVO 2020 Annual Meeting of the Association for Research in Vision and Ophthalmology CANCELLED No further updates available Abstracts available
ASA-USA 2020 American Surgical Association’s 140th Annual Meeting CANCELLED No further updates available No information available
ASBrS 2020 21st Annual Meeting of American Society of Breast Surgeons CANCELLED No further updates available Preliminary program available
ASCRS 2020 2020 ASCRS Annual Scientific Meeting CANCELLED No further updates available Preliminary program available
ASCRS-ASOA 2020 2020 ASCRS-ASOA Annual Meeting CANCELLED No further updates available Abstracts available
ASPHO 2020 American Society of Pediatric Hematology / Oncology Annual Meeting CANCELLED No further updates available Preliminary program available
ASPN-PAS 2020 ASPN-Pediatric Academic Societies Meeting CANCELLED No further updates available No information available
ATS 2020 American Thoracic Society International Conference CANCELLED Looking for Virtual Options Titles available
AUA 2020 American Urological Association Annual Meeting CANCELLED No further updates available Preliminary program available
BMUC 2020 7th Belgian Multidisciplinary Meeting on Urological Cancers CANCELLED No further updates available Preliminary program available
BRASCRS 2020 XIX Congresso Internacional de Catarata e Cirurgia Refrativa CANCELLED Next congress will be in 2021. No further updates available Preliminary program available
BSG 2020 Annual Meeting of the British Society of Gastroenterology CANCELLED Next congress will be in February 8-11, 2021 Preliminary program available
BSH 2020 British Society for Haematology 60thAnnual Scientific Meeting CANCELLED Next Congress will be in April 25-27, 2021, Liverpool Preliminary program available
CAN-ACN 2020 14th Annual Canadian Neuroscience Meeting CANCELLED Next congress will be in May 2021 Preliminary program available
CCOLD 2020 12th Annual Canadian Conference on Lymphoproliferative Disorders CANCELLED No further updates available Preliminary program available
CIMT 2020 18th Annual Meeting of the Association for Cancer Immunotherapy CANCELLED No further updates available Preliminary program available
CIS 2020 Clinical Immunology Society Annual Meeting CANCELLED No further updates available Titles available
CMSC 2020 34th Annual Meeting of the Consortium of Multiple Sclerosis Centers CANCELLED No further updates available Preliminary program available
CNSF 2020 55th Canadian Neurological Sciences Federation Annual Congress CANCELLED No further updates available No information available
COSM 2020 Combined Otolaryngology Spring Meetings CANCELLED Next congress will be in April 7-11, 2021 No information available
CPS 2020 41st Annual CPS Scientific Meeting CANCELLED No further updates available Preliminary program available
CRC 2020 13th Annual Canadian Respiratory Conference CANCELLED Next congress will be in April 8-10, 2021, Quebec, Canada Titles available
CSCTR-MWAFMR 2020 2020 Midwest Clinical & Translational Research Meeting of CSCTR and MWAFMR CANCELLED No further updates available Preliminary program available
CSPR 2020 California Society of Pulmonary Rehabilitation Annual Conference CANCELLED No further updates available No information available
CUGH 2020 11th Annual Conference of The Consortium of Universities for Global Health CANCELLED Next congress will be in March 12-14, 2021, Houston, Texas Preliminary program available
DDG 2020 55th Deutsche Diabetes Gesellschaft Diabetes Kongress CANCELLED No further updates available Abstracts available
DDW 2020 Digestive Disease Week CANCELLED Looking for Virtual Options Titles available
DECENNIAL 2020 6th Decennial International Conference on Healthcare Associated Infections CANCELLED No further updates available Abstracts available
DGIM 2020 126th Congress of the German Society for Internal Medicine CANCELLED No further updates available No information available
EADV-Sp 2020 16th EADV Spring Symposium CANCELLED No further updates available Titles available
ECCMID 2020 30th European Congress of Clinical Microbiology & Infectious Diseases CANCELLED No further updates available Titles available
EHRA 2020 The Annual Congress of the European Heart Rhythm Association CANCELLED No further updates available Preliminary program available
ELCC 2020 The European Lung Cancer Congress CANCELLED No further updates available Preliminary program available
EMN 2020 2nd European Myeloma Network Meeting CANCELLED Next congress will be in March 4-6, 2021 No information available
ENDO 2020 Annual Meeting and Expo of The Endocrine Society CANCELLED Looking for virtual options Abstracts available
ESO-EONS 2020 13th ESO-EONS Masterclass in Oncology Nursing CANCELLED No further updates available Preliminary program available
ESO-ESMO-LA 2020 6th ESO-ESMO Latin-American Masterclass in Clinical Oncology CANCELLED No further updates available Preliminary program available
ESSTS 2020 13th European Conference on Tourette Syndrome & Tic Disorders CANCELLED Next congress will be in 2021. No further updates available Preliminary program available
GC-IDD 2020 53rd Annual Gatlinburg Conference on Research and Theory in Intellectual and Developmental Disabilities CANCELLED Next congress will be in April 5-8, 2021, Kansas City, USA Preliminary program available
GICC 2020 5th St.Gallen International Gastrointestinal Cancer Conference-Focus on Oligometastatic Disease CANCELLED No further updates available No information available
GRC-FXA 2020 Gordon Research Conference-Fragile X and Autism-Related Disorders CANCELLED Next congress will be in 2022. No further updates available Preliminary program available
GSC 2020 9th Annual Global Spine Congress CANCELLED No further updates available No information available
GVF 2020 2020 GVF Annual Scientific Symposium CANCELLED Looking for virtual options No information available
HAEGC 2020 5th HAE Global Conference CANCELLED No further updates available No information available
ICE-ISE-ISHNE 2020 Joint meeting of the 47th Congress of the International Society of Electrocardiology and 20th Congress of the International Society for Holter and Noninvasive Electrocardiology CANCELLED No further updates available No information available
ICIMH 2020 International Congress on Integrative Medicine and Health CANCELLED No further updates available No information available
ICPMCSSPCP 2020 16th International Conference on Pediatric Mechanical Circulatory Support Systems & Pediatric Cardiopulmonary Perfusion CANCELLED No further updates available No information available
ILTS 2020 2020 Joint International Congress of the International Liver Transplantation Society, ELITA and LICAGE CANCELLED Next congress will be in May 5-8, 2021, Istanbul Abstracts available
IMMUNOLOGY 2020 IMMUNOLOGY 2020 Meeting CANCELLED Next congress will be in May 12-16, 2021, Philadelphia, PA Preliminary program available
IPCC 2020 24th International Pigment Cell Conference CANCELLED No further updates available No information available
ISHLT 2020 ISHLT 40th Anniversary Meeting and Scientific Sessions CANCELLED No further updates available Preliminary program available
ISN-WCN 2020 ISN World Congress of Nephrology CANCELLED No further updates available Abstracts available
ISPD EuroPD 2020 Joint Congress of the International Society of Peritoneal Dialysis and EuroPD CANCELLED Next congress will be in March, 27-30, 2021, Glasgow No information available
ISPOR 2020 Annual Meeting of International Society for Pharmacoeconomics and Outcomes Research CANCELLED Looking for virtual options Abstracts available
ISTH 2020 XXVIII Congress of the International Society on Thrombosis and Haemostasis CANCELLED No further updates available Preliminary program available
IUA 2020 29th World Congress of the International Union of Angiology CANCELLED No further updates available Preliminary program available
JGCC 2020 The 92nd Annual Meeting of the Japanese Gastric Cancer Association CANCELLED No further updates available No information available
JSHCT 2020 The 42nd Annual Meeting of the Japan Society for Hematopoietic Cell Transplantation CANCELLED No further updates available Preliminary program available
KSMCB-C4 2020 KSMCB-Advances in Cancer Immunotherapy CANCELLED No further updates available Titles available
KSMCB-D1 2020 Keystone Symposia on Molecular and Cellular Biology Asthma: Making New Discoveries into Better Therapies CANCELLED No further updates available Preliminary program available
Mayo GH 2020 Mayo Clinic Gastroenterology & Hepatology 2020 CANCELLED No further updates available Preliminary program available
NAF-AAC 2020 63rd NAF Annual Ataxia Conference CANCELLED No further updates available No information available
NATCON 2020 National Council for Behavioral Health 2020 CANCELLED Next congress will be in May 3-5, 2021, Denver, CO, USA Preliminary program available
NCoBC 2020 The 30th Annual Interdisciplinary Breast Center Conference CANCELLED Next congress will be in March 19-24, 2021 Titles available
NDLR 2020 8th New Directions in Leukaemia Research Meeting CANCELLED Next congress will be in March 09-11, 2021, Brisbane Preliminary program available
Nephrology 2020 Comprehensive Review of Nephrology 2020 CANCELLED Next congress will be in Mar 14-19, 2021, Boston, MA, USA Preliminary program available
NFID-ACVR 2020 NFID-The Annual Conference on Vaccinology Research CANCELLED No further updates available Titles available
NIC 2020 49th National Immunization Conference CANCELLED No further updates available No information available
NMTR 2020 13th UK Neuromuscular Translational Research Conference CANCELLED No further updates available Preliminary program available
NTCLD 2020 35th Annual New Treatments in Chronic Liver Disease CANCELLED No further updates available Preliminary program available
OARSI 2020 OARSI 2020 World Congress CANCELLED No further updates available Preliminary program available
Onkologidagarna 2020 Onkologidagarna 2020 CANCELLED No further updates available Titles available
ONS 2020 45th Annual Congress of Oncology Nursing Society CANCELLED Next congress will be in April 22-25, 2021 Abstracts available
PCNA 2020 PCNA’s 26th Annual Cardiovascular Nursing Symposium CANCELLED No further updates available Preliminary program available
RCOG 2020 Royal College of Obstetricians & Gynaecologists World Congress CANCELLED Next congress will be in January 28-30, 2021 Preliminary program available
RCOphth 2020 The Royal College of Ophthalmologists Annual Congress CANCELLED No further updates available Preliminary program available
RPA 2020 Renal Physicians Association Annual Meeting 2020 CANCELLED No further updates available No information available
SBI-ACR 2020 SBI-ACR Breast Imaging Symposium 2020 CANCELLED No further updates available Preliminary program available
SCAI 2020 Society for Cardiovascular Angiography and Interventions Scientific Sessions CANCELLED No further updates available Titles available
SCVS 2020 48th Annual Symposium of the Society for Clinical Vascular Surgery CANCELLED Next congress will be in March 13-17, 2021 Abstracts available
SESAUA 2020 84th Annual Meeting of the Southeastern Section of the AUA CANCELLED No further updates available Titles available
SEUD 2020 6th Congress of the Society of Endometriosis and Uterine Disorders CANCELLED Looking for virtual options Preliminary program available
SGO 2020 Society of Gynecologic Oncologists Annual Meeting on Women’s Cancer CANCELLED Looking for webinars Titles available
SHM 2020 Society of Hospital Medicine Annual Conference CANCELLED No further updates available Preliminary program available
SIR 2020 Annual Scientific meeting of the Society of Interventional Radiology CANCELLED No further updates available Preliminary program available
SIRS 2020 2020 Annual Congress of the Schizophrenia International Research Society CANCELLED No further updates available Abstracts available
SMASCP 2020 31st Annual Spring Conference on Pediatrics CANCELLED No further updates available Preliminary program available
SOBP 2020 75th Annual Scientific Conference of Society of Biological Psychiatry CANCELLED No further updates available Abstracts available
SRI 2020 67th Annual Meeting of the Society for Reproductive Investigation CANCELLED No further updates available No information available
SSAT 2020 61st Annual Meeting of the Society for Surgery of Alimentary Tract CANCELLED No further updates available Preliminary program available
TAT 2020 18th International Congress on Targeted Anticancer Therapies CANCELLED No further updates available Titles available
USANZ 2020 The Urological Society of Australia and New Zealand 73rd Annual Scientific Meeting CANCELLED No further updates available Preliminary program available
WFH 2020 World Congress of the World Federation of Hemophilia CANCELLED No further updates available Preliminary program available
AAT-ADPD 2020 The 2nd AAT-AD/PD Focus Meeting ON SCHEDULE To be replaced with an online meeting Abstracts available
ACC 2020 The American College of Cardiology’s 69th Annual Scientific Session & Expo ON SCHEDULE To be replaced with an online meeting Abstracts available
AIDS 2020 The 23rd International AIDS Conference ON SCHEDULE To be replaced with an online meeting No information available
ASAM 2020 51st Annual Conference of the American Society of Addiction Medicine ON SCHEDULE To be replaced with an online meeting Abstracts available
ASCO 2020 American Society of Clinical Oncology Annual Meeting ON SCHEDULE To be replaced with an online meeting Titles available
ASPEN 2020 ASPEN Nutrition Science & Practice Conference ON SCHEDULE To be replaced with an online meeting Preliminary program available
ATVB-PVD-GPM 2020 Vascular Discovery: From Genes to Medicine Scientific Sessions 2020 ON SCHEDULE To be replaced with an online meeting Preliminary program available
CNS 2020 27th Annual Meeting of Cognitive Neuroscience Society ON SCHEDULE To be replaced with an online meeting Abstracts available
COPHy EU 2020 11th Annual Congress on Controversies in Ophthalmology: Europe ON SCHEDULE To be replaced with an online meeting Abstracts available
CPNP 2020 23rd Annual Meeting of the College of Psychiatric and Neurologic Pharmacists ON SCHEDULE To be replaced with an online meeting Preliminary program available
CROI 2020 The Annual Conference on Retroviruses and Opportunistic Infections ON SCHEDULE To be replaced with an online meeting Abstracts available
EAN 2020 6th Congress of the European Academy of Neurology ON SCHEDULE To be replaced with an online meeting Titles available
ENETS 2020 17th Annual ENETS Conference ON SCHEDULE To be replaced with an online meeting Titles available
ERA-EDTA 2020 57th ERA-EDTA Annual Congress ON SCHEDULE To be replaced with an online meeting Titles available
EULAR 2020 Annual Congress of European League Against Rheumatism ON SCHEDULE To be replaced with an online meeting Titles available
HEI 2020 Health Effects Institute Annual Conference 2020 ON SCHEDULE To be replaced with an online meeting Titles available
HIMSS 2020 HIMSS Global Health Conference & Exhibition ON SCHEDULE To be replaced with an online meeting Abstracts available
ICUC 2020 XI International Congress of Uro-Oncology ON SCHEDULE To be replaced with an online meeting Preliminary program available
MNRS 2020 44th Annual Research Conference of the Midwest Nursing Research Society ON SCHEDULE To be replaced with an online meeting Abstracts available
NIH-AACR Immunology 2020 NIH-AACR Cancer, Autoimmunity, and Immunology Conference ON SCHEDULE To be replaced with an online meeting Preliminary program available
NKF-CSM 2020 NKF 2020 Spring Clinical Meetings ON SCHEDULE To be replaced with an online meeting Abstracts available
PCD 2020 2020 Prevent Cancer Dialogue: Prevention, Screening, Action ON SCHEDULE To be replaced with an online meeting Preliminary program available
QCOR 2020 Quality of Care and Outcomes Research Scientific Sessions ON SCHEDULE To be replaced with an online meeting Preliminary program available
RDD 2020 Respiratory Drug Delivery 2020 ON SCHEDULE To be replaced with an online meeting Titles available
Rx Summit 2020 Rx Drug Abuse & Heroin Summit ON SCHEDULE To be replaced with an online meeting Preliminary program available
SWOG 2020 SWOG Spring Group Meeting ON SCHEDULE To be replaced with an online meeting No information available
Read More …

COVID-19 Treatments in Clinical Trials

March 30, 2020

Larvol’s heatmap is a visual landscape of COVID-19 treatments in clinical trials by condition.

For full access, contact us at info@larvol.com.

 

Read More …

COVID-19 Top News – March 30, 2020

March 30, 2020

Coronavirus Therapy / Cocrystal Pharma
Cocrystal Pharma reports 2019 financial results and outlines expected value-driving milestones for 2020 (GlobeNewswire, Cocrystal Pharma, Inc.) – Mar 30, 2020 – “Advancing preclinical COVID-19 Coronavirus program leveraging patent rights recently acquired from Kansas State University Research Foundation (“KSURF”)….Q2 2020: File patent application….Q2/Q3 2020: Develop COVID-19 inhibitors using proprietary platform technology….H2 2020: Initiate preclinical studies of COVID-19 inhibitors.”

 

Kevzara (sarilumab) / Asahi Kasei, Regeneron, Sanofi
Sanofi: First patient outside U.S. treated in global Kevzara (sarilumab) clinical trial program for patients with severe Covid-19 (GlobeNewswire) – Mar 30, 2020 – “The global clinical program has now been initiated in Italy, Spain, Germany, France, Canada, Russia and the United States – all countries that have been impacted by COVID-19….This is the second multi-center, double-blind, Phase 2/3 trial as part of the Kevzara COVID-19 program….The trial outside of the U.S. will assess the safety and efficacy of adding a single intravenous dose of Kevzara to usual supportive care, compared to supportive care plus placebo. The trial has an adaptive design with two parts and is anticipated to enroll approximately 300 patients.”

 

GC LabCell to develop Covid-19 treatment using NK-cell (Korea Biomedical Review) – Mar 30, 2020 – “Green Cross LabCell said that it has begun research into a COVID-19 medication, with a hope to start a clinical trial by the second half of 2020 in Korea and the United States….The company will begin to develop the COVID-19 treatment through a joint study with a biotechnology company, KLEO Pharmaceuticals….One of them is to develop a COVID-19 treatment with its NK cell therapy….The other one uses ARMs, which acts as a neutralizing antibody of NK treatment, to develop COVID-19 treatment. The companies will conduct the research with the National Institute of Allergy and Infectious Disease of the National Institutes of Health and a research team led by Choi Young-ki of the Chungbuk National University College of Medicine.”

 

hydroxychloroquine / Generic mfg.; chloroquine phosphate / Generic mfg.
FDA issues emergency use authorization of Trump-touted drug to treat coronavirus (The Daily Wire) – Mar 30, 2020 – “Food and Drug Administration (FDA) issued an emergency use authorization for hydroxychloroquine and chloroquine…in the fight against the China-originated novel coronavirus….The United States Department of Health & Human Services (HHS) announced in a statement…that the FDA will allow the drugs to be ‘donated to the Strategic National Stockpile to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible,’ a Politico report said.”

 

DPX-COVID-19 / IMV Inc
IMV Inc. provides updates on the development of DPX-COVID-19 vaccine and ongoing business and clinical operations (Businesswire) – Mar 30, 2020 – “In collaboration with Gary Kobinger, Ph.D….preclinical assays in animal models are also planned in April through May of this year….In collaboration with Joanne Langley, M.D. at the Canadian Center for Vaccinology (CCfV) and the Canadian Immunization Research Network (CIRN) the design of a Phase 1 clinical study in 48 healthy subjects has been completed and clinical sites identified in both Nova Scotia and Quebec. IMV has initiated discussions with Health Canada in preparation for a Clinical Trial Application (CTA). A meeting is being scheduled in the week of April 20, 2020 with the goal to initiate the clinical study in the summer of 2020.”

 

bucillamine / Revive Therap
Revive Therapeutics provides corporate update on its covid-19 and infectious diseases programs (GlobeNewswire, Revive Therapeutics Ltd.) – Mar 30, 2020 – “The Company is finalizing its regulatory package and clinical study plan for Bucillamine in the treatment of COVID-19 and it will submit for regulatory approval, by way of an IND application submission to the U.S. FDA, to investigate Bucillamine in a proposed Phase 2 clinical study. Revive will also seek to expand the clinical investigation of Bucillamine for COVID-19 in APAC regions, with a particular interest in Japan and South Korea.”

 

AdCOVID (COVID-19 vaccine) / Altimmune
Altimmune and the University of Alabama at Birmingham to collaborate on development of single-dose, intranasal Covid-19 vaccine (GlobeNewswire, Altimmune, Inc.) – Mar 30, 2020 – “Altimmune, Inc….today announced that it is launching a collaboration with the University of Alabama at Birmingham (UAB) on the development of its single-dose, intranasal COVID-19 vaccine, named AdCOVID. In response to the urgent demand posed by the COVID-19 global pandemic, Altimmune has created a COVID-19 vaccine candidate and is currently preparing for immunogenicity studies and manufacture of Phase 1 clinical trial material. Initially, Altimmune will work with UAB investigators on preclinical animal studies and characterization of the vaccine immunogenicity with the goal of enabling a Phase 1 trial in Q3 of this year.”

 

Avigan (favipiravir) / Fujifilm Holdings
Russia now has three drugs that can help treat Covid-19 – Russian Academy of Sciences (UrduPoint) – Mar 30, 2020 – “Three antiviral drugs that can be used to treat COVID-19 were developed in Russia…Chekhonin stated that the antiviral drug triazavirin was created several years ago…now being tested by Chinese scientists for its ability to treat COVID-19….The leading academician also stated that another drug, based on the Japanese-made antiviral treatment favipiravir….Another viral drug, fortepren, has also passed clinical trials and should be assessed for its ability to treat COVID-19, the academician stated.”

 

Coronavirus Vaccine / J&J, Beth Israel Deaconess Medical Center
Johnson & Johnson announces a lead vaccine candidate for Covid-19; Landmark new partnership with U.S. Department of Health & Human Services; And commitment to supply one billion vaccines worldwide for emergency pandemic use (PRNewswire) – Mar 30, 2020 – “Johnson & Johnson…today announced the selection of a lead COVID-19 vaccine candidate from constructs….The significant expansion of the existing partnership between the Janssen Pharmaceutical Companies of Johnson & Johnson and the Biomedical Advanced Research and Development Authority (BARDA)….The Company expects to initiate human clinical studies of its lead vaccine candidate at the latest by September 2020 and anticipates the first batches of a COVID-19 vaccine could be available for emergency use authorization in early 2021…”

 

FDA warns against use of Prodex-B as antiviral treatment for Covid-19 (GMA News) – Mar 30, 2020 – “The Food and Drug Administration (FDA)…warned the public against the use of Prodex-B as an antiviral treatment for coronavirus disease 2019 (COVID-19). In an advisory, the FDA said the drug cocktail composed of Procaine, Dexamethasone, and Vitamin B is not registered. The use of such unregistered drug may harm the patient, it added….Earlier in the day, the Department of Health also warned that other approved off-label drugs for COVID-19 treatment shall only be administered at hospitals and shall not be used for self-medication.”

 

Pluristem treated first three Covid-19 patients in Israel under compassionate use (GlobeNewswire, Pluristem Therapeutics, Inc.) – Mar 30, 2020 – “Company is in discussions with regulators in the U.S. and Europe to define its clinical strategy for COVID-19….Pluristem Therapeutics Inc….it has dosed three patients in two different hospitals in Israel under a compassionate use program for the treatment of COVID-19, as approved by the Israeli Ministry of Health. Pluristem expects to enroll additional patients in Israel in the coming days and anticipates providing updates on clinical outcomes once significant data has been gathered.””

Read More …

COVID-19 Top News – March 29, 2020

March 29, 2020

aviptadil intravenous (RLF-100) / Relief Therap, NeuroRx
Relief Therapeutics, NeuroRx get FDA nod to start coronavirus trial (Reuters) – Mar 29, 2020 – “The U.S. Food & Drug Administration has authorised the start of a mid-stage trial by U.S.-Israeli NeuroRx and Relief Therapeutics for the use of Aviptadil to treat Acute Respiratory Distress in coronavirus patients….They are recruiting study sites and pharmacies to begin a phase 2 trial. The FDA issued a ‘study may proceed’ letter 24 hours after their investigational new drug application.”

 

chloroquine phosphate / Generic mfg.
Covid-19: NIMR begins test trial tomorrow – Prof Salako (Vanguard Media Limited) – Mar 29, 2020 – “…Nigerian Institute of Medical Research, NIMR, will begin clinical trials on three rapid testing kits for the disease tomorrow. Also, the institute will commence clinical trials on the efficacy of chloroquine on people who tested positive to COVID-19 and those showing symptoms but not confirmed yet.”

 

hydroxychloroquine / Generic mfg.; azithromycin / Generic mfg.
US coronavirus: Trump asks FDA to immediately approve malaria drug and antibiotic combo (InfoSurHoy.com) – Mar 29, 2020 – “…the president urged the Food and Drug Administration in a tweet to speed approval for a malarial drug and an antibiotic to treat coronavirus patients…‘HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game changers in the history of medicine’….”

 

azithromycin / Generic mfg.; hydroxychloroquine / Generic mfg.
Covid 19 treatment: French expert says second study shows malaria drug helps fight coronavirus (Financialexpress) – Mar 29, 2020 – “Dr Philippe Gautret, who was part of the team behind Raoult’s latest findings, admitted that they only used the combination of drugs on ‘patients who had not been showing signs of being seriously ill after admission’ to the hospital….They said the testing was not carried out in a controlled study and that the results were purely ‘observational’. Dr Raoult…said his new study of 80 patients showed that four out of five of those treated with the drug had ‘favourable’ outcomes.”

 

Fighting Covid-19: Houston hospital first in US to try coronavirus blood transfusion therapy (New Indian Express) – Mar 29, 2020 – “A prominent US hospital here has infused the blood of a patient, who has recovered from COVID-19, into a critically ill patient, becoming the first medical facility in the country to try the experimental therapy….Methodist…began recruiting blood plasma donors from among 250 patients who have tested positive for the virus at the system’s hospitals.”

 

UofL researchers focus on coronavirus treatment, testing cells growing quickly in host tobacco plants (NKyTribune) – Mar 29, 2020 – “The University of Louisville’s biocontainment laboratory is being called upon in research efforts focusing on the coronavirus and the disease it causes, COVID-19, and a Kentucky crop could be a key….The research goal is to identify the best potential treatment option that could eventually be tested in humans, first at UofL to gauge its safety and efficacy and then later at the University of Pittsburgh and other clinical trial sites to continue to test its effectiveness….Some of the compounds are already showing promise in the laboratory.”

 

Telehealth, new social media sources and a glimmer of hope that Covid-19 curve is flattening (The RiotACT) – Mar 29, 2020 – “The Prime Minister’s major announcement today concerned the immediate rollout of Telehealth from Monday morning and ways to distribute official information via a new What’s App feature and the Apple coronavirus app….Health Minister Greg Hunt described ‘a time of profound and understandable stress, anxiety, depression, isolation, and need for access to services’, but said the telehealth changes enacted in 10 days would otherwise have taken 10 years to accomplish and would mean substantial assistance was available during the crisis.”

Read More …

COVID-19 Top News – March 28, 2020

March 28, 2020

lopinavir/ritonavir / Generic mfg.; hydroxychloroquine / Generic mfg.; remdesivir (GS-5734) / Gilead; chloroquine phosphate / Generic mfg.
A patient in Norway is the first to enroll in a global ‘solidarity trial’ testing 4 coronavirus treatments (Business Insider) – Mar 28, 2020 – “Hoie said the trial starts today, and that the first patient is somone at Oslo Universoty Hospital….The trial…includes more than 45 countries around the world…”

 

US biotech firm wants to test its pneumonia treatment in Covid-19 patients – Mar 28, 2020 – “BioAegis Therapeutics has been testing a protein called gelsolin to treat pneumonia….BioAegis has applied to the FDA for rapid authorization to begin a clinical trial of its treatment for COVID-19 patients that are on or nearly to the point of needing ventilators.”

 

Study shows good results with plasma treatment for Covid-19 (The Hindu) – Mar 28, 2020 – “…Convalescent plasma transfusion may be helpful in the treatment of critically ill patients with COVID-19 and ARDS….While the cohort is small, there is less scepticism about the study results, experts argue, because the method (convalescent plasma) has worked well for other conditions….’Following plasma transfusion, body temperature normalised within 3 days in 4 of 5 patients, the Sequential Organ Failure Assessment score decreased, and the ratio that determines severity of ARDS increased within 12 days….Viral loads also decreased and became negative within 12 days after the transfusion’.”

 

lopinavir/ritonavir / Generic mfg.; chloroquine phosphate / Generic mfg.; hydroxychloroquine / Generic mfg.; remdesivir (GS-5734) / Gilead
India to participate in WHO solidarity trial for developing potential drugs for Covid-19 – Mar 28, 2020 – “Mr Gangakhedkar also informed that India has indicated willingness to go for vaccine trials for country’s population….Our correspondent reports that WHO’s Solidarity trial is expected to witness participation from many countries including Thailand, Argentina, Canada, France, Iran, and Spain. The trial will not only test different drugs but will also compare their effectiveness.”

 

lopinavir/ritonavir / Generic mfg.; hydroxychloroquine / Generic mfg.; remdesivir (GS-5734) / Gilead; chloroquine phosphate / Generic mfg.
WHO enrolls Spain and Norway for Covid-19 initial clinical trial (Biospectrumasia) – Mar 28, 2020 – “Spain and Norway are ready to enrol their patients for COVID-19 clinical trial….’More the countries join the trial, the faster we will have results. In the meantime, we call on individuals & countries to refrain from using therapeutics that have not been demonstrated to be effective in the treatment of COVID-19′.”

 

mRNA-1273 / Moderna Therapeutics
US coronavirus vaccine trial expands to second test location – Mar 28, 2020 – “A coronavirus vaccine study has expanded to a second location, with new volunteers for the potentially COVID-19-preventing injection being sought in Atlanta….Now, Emory University in Atlanta plans to enroll a second cohort as the Phase 1 trial expands its footprint. In total it’s expected to amount to 45 participants spread across both sites.”

Read More …

COVID-19 Top News – March 27, 2020

March 27, 2020

Kevzara (sarilumab) / Asahi Kasei, Regeneron, Sanofi; remdesivir (GS-5734) / Gilead
N.J. hospital flooded by Covid-19 patients begins clinical drug trials (NJ.com) – Mar 27, 2020 – “Holy Name Medical Center…is conducting trials of two drugs to treat the disease caused by the novel coronavirus. ‘We are trying to do clinical trials of a drug, Kevzara, and expanded access (compassionate use) of the drug remdesivir,’ Saggar said.”

 

ChAdOx1 nCoV-19 / Jenner Institute, University of Oxford
Oxford Covid-19 vaccine programme opens for clinical trial recruitment (Mirage News) – Mar 27, 2020 – “University of Oxford researchers…have started screening healthy volunteers (aged 18-55) today for their upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region….The team will enrol healthy volunteers aged between 18 – 55….The trial…will recruit up to 510 volunteers, who will receive either the ChAdOx1 nCoV-19 vaccine or a control injection for comparison.”

 

AdCOVID (COVID-19 vaccine) / Altimmune
Altimmune announces financial results for the year ended December 31, 2019 and provides a corporate update (GlobeNewswire, Altimmune, Inc.) – Mar 27, 2020 – “…Company began development of AdCOVID, a vaccine candidate to protect against COVID-19. The Company designed and created the vaccine candidate…and plans to begin animal testing in Q2 2020. The Company is engaged in discussions with a number of organizations who are addressing this crisis, including The United States Medical Countermeasures Task Force, The World Health Organization, academia, and other institutions engaged in the effort.”

 

leronlimab (PRO 140) / CytoDyn, Vyera Pharma
CytoDyn files FDA-suggested modifications to IND and protocol for phase 2 clinical trial for Covid-19 patients with mild to moderate indications and a second randomized protocol for all Covid-19 patients in severe condition will be filed next week per FDA recommendation (GlobeNewswire, CytoDyn Inc.) – Mar 27, 2020 – “CytoDyn Inc….announced today that, at the suggestion of the U.S. Food and Drug Administration (FDA), the Company filed another round of modifications to its IND and protocol for a Phase 2 clinical trial with leronlimab (PRO 140). In addition, the FDA suggested the Company file a second randomized protocol for all COVID-19 patients in severe condition, so as to preclude each physician from filing an emergency IND for every patient to be treated with leronlimab….The first Phase 2 clinical trial…is a randomized, double blind, placebo-controlled study to evaluate the efficacy and safety of leronlimab in patients with mild to moderate documented COVID-19 illness and calls for 75 planned patients in up to 10 centers in the United States.”

 

Kevzara (sarilumab) / Asahi Kasei, Regeneron, Sanofi
Two clinical studies to treat Covid-19 launched (Medical Xpress) – Mar 27, 2020 – “UC Davis is one of up to 50 sites in the U.S. assessing sarilumab….Approximately 400 hospitalized patients age 18 and older with acute COVID-19 infection can be enrolled in the study nationwide….The researchers will be determining whether the health of individuals with high IL-6 levels and severe/critical levels of infection improve with the drug. The study is sponsored by the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. Timothy Albertson, professor and chair of the Department of Internal Medicine, is leading the study at UC Davis.”

 

Arcturus Covid-19 vaccine to benefit from Duke-NUS genetic correlation system (GlobeNewswire, Arcturus Therapeutics, Inc.) – Mar 27, 2020 – “Arcturus Therapeutics…today provided details about the Company’s strategy to rapidly learn about the safety and efficacy profile of its COVID-19 vaccine using Duke-NUS’ genetic correlation system….Arcturus’ COVID-19 vaccine, LUNAR-COV19, is based on its STARR™ and LUNAR® technologies.”

 

EIDD-2801 / Emory University, Ridgeback Biotherap
Emory-discovered antiviral is poised for Covid-19 clinical trials (Chemical & Engineering News) – Mar 27, 2020 – “A small-molecule antiviral discovered by Emory University chemists could soon start human testing against COVID-19….That’s the plan of Ridgeback Biotherapeutics, which licensed the compound, EIDD-2801, from an Emory nonprofit….EIDD-2801 lacks human safety data. Ridgeback founder and CEO Wendy Holman says she expects the US Food and Drug Administration to give the green light for a Phase I study in COVID-19 infections within “weeks, not months.””

 

remdesivir (GS-5734) / Gilead
Two clinical studies to treat Covid-19 launched (Medical Xpress) – Mar 27, 2020 – “UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19….UC Davis is one of approximately 75 sites worldwide evaluating the benefits of remdesivir for severe COVID-19 infection….The study will enroll up to 440 patients over the next several months, including about 10 or more at UC Davis….It is part of the study recently launched at the University of Nebraska.”

 

leronlimab (PRO 140) / CytoDyn, Vyera Pharma
Leronlimab used in seven patients with severe Covid-19 demonstrated promise with two intubated patients in ICU, removed from ICU and extubated with reduced pulmonary inflammation (GlobeNewswire, CytoDyn Inc.) – Mar 27, 2020 – “CytoDyn Inc….announced today the three-day results post-leronlimab treatment of the first four patients under an Emergency Investigational New Drug (EIND)….’We found that patients with severe COVID-19 disease are in the midst of immunologic chaos which includes the cytokine storm. Our companion diagnostics showed that after three days of therapy, the immune profile in these patients approached normal levels and the levels of cytokines involved in the cytokine storm were much improved’.”

 

Rare case of Pulmonary Necrotic Rhodococcus equi infection in a Kidney Pancreas Transplant Recipient. (NKF-CSM 2020) – Mar 27, 2020 – Abstract #463; “At the time of presentation, he was on tacrolimus, mycophenolate mofetil, prednisone and basiliximab for immunosuppression…He was prescribed azithromycin, doxycycline, and ciprofloxacin by his local providers with no improvement…He was started on IV vancomycin, meropenem for 6 weeks and his symptoms improved…He recieved voriconazole for his aspergilllus for 12 months… R.equi is a unique Acid fast positive cocci and a intracellular pathogen.We report a very rare case of Rhodococcus infection in a kidney pancreas transplant recipient which was successfully treated without surgical intervention. Choice of antibiotics was challenging while maintaining dual organ transplant function and avoiding acute rejection.”

Read More …

COVID-19 Top News – March 26, 2020

March 26, 2020

Berkeley Lights announces the creation of the Global Emerging Pathogen Antibody Discovery Consortium (GEPAD) to address Covid-19 and other viruses (PRNewswire) – Mar 26, 2020 – “In collaboration with Vanderbilt University Medical Center, La Jolla Institute for Immunology and Emory University , viral neutralization workflows using the Berkeley Lights platform are being accelerated in response to the epidemic coronavirus….The consortium will use the Berconey Lights Beacon platform to discover antibodies using blood from patients in remission as the basis for treatment, COVID-19 being the first target.”

 

ExThera’s affinity blood filter is used to treat Covid-19 Patients – Mar 26, 2020 – “Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin soon in France and the USA….ExThera has received clinician interest in individual emergency use of Seraph 100 in the USA and we expect COVID-19 treatments to begin here soon, when they meet the criteria outlined in the FDA Guidance.”

 

Relief Therapeutics and NeuroRx, Inc. file FDA IND for Aviptadil to treat Covid-19-induced respiratory distress (PRNewswire) – Mar 26, 2020 – “RELIEF THERAPEUTICS Holding AG…filed an Investigational New Drug (IND) Application with the US FDA for a phase 2 trial of RLF-100 (Aviptadil) in the treatment of Acute and Moderate Respiratory Distress in patients infected by the COVID-19 coronavirus….Relief also holds a US patent for Aviptadil and proprietary manufacturing processes for its synthesis.”

 

remdesivir (GS-5734) / Gilead
Gilead rescinds orphan status request for Covid-19 drug (pharmaphorum) – Mar 26, 2020 – “Gilead decided to rescind the request for orphan status after drug pricing campaigners accused the company of gaming US drug laws to maximise any profits made from remdesivir should it get approved….While Gilead did not acknowledge the pricing row in its brief statement saying it had rescinded the request, the company noted that orphan status also waives the need for a paediatric study plan that can take 210 days to review.”

 

FDA grants VERO Biotech expanded access emergency use for the treatment of patients with COVID-19, with the Genosyl DS, the first and only FDA-approved tankless system for the delivery of inhaled nitric oxide (PRNewswire) – Mar 26, 2020 – “VERO Biotech LLC…announced that the U.S. Food and Drug Administration (FDA) has granted ‘expanded access emergency use’ allowing its proprietary inhaled nitric oxide (iNO) delivery system, GENOSYL® DS, to immediately be used for the treatment of cardiopulmonary symptoms associated with COVID-19.”

 

Beroni Group announces submission of Emergency Use Authorization to US FDA for its COVID-19 rapid test detection kit (GlobeNewswire) – Mar 26, 2020 – “Beroni Group….announces submission for an Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for its IgG/IgM antibody SARS-CoV-2 rapid test detection kit.”

 

Dynavax and CEPI announce collaboration to support global effort to develop a vaccine for coronavirus (COVID-19) (GlobeNewswire, Dynavax Technologies Corporation) – Mar 26, 2020 – “Dynavax Technologies Corporation…and the Coalition for Epidemic Preparedness Innovations (CEPI) today announced a collaboration supporting the global effort to develop a vaccine to prevent the coronavirus (COVID-19). Dynavax will make the Company’s proprietary toll-like receptor 9 (TLR9) agonist adjuvant, CpG 1018TM, available for the development of effective vaccines against COVID-19….CEPI and Dynavax will work together to identify and coordinate engagements with entities around the world working on COVID-19 vaccines. The focus of this collaboration is to identify programs that could benefit from combination with CPG 1018 to provide a more rapid or robust immune response.”

Read More …

COVID-19 Treatments in Clinical Trials

March 24, 2020

Larvol’s heatmap is a visual landscape of COVID-19 treatments in clinical trials by condition.

For full access, contact us at info@larvol.com.

Read More …

COVID-19 Content

March 24, 2020

Click here to sign-up for Larvol’s COVID-19 related reports:

 

  1. Status of Scientific Conferences
  2. A COVID-19 Pulse News & Trials Report
  3. A COVID-19 KOL Report

 

Read More …

COVID-19 Top News – March 19, 2020

March 19, 2020

Entos to develop Fusogenix DNA vaccine to prevent Covid-19 infections (Pharmaceutical Business Review (PBR)) – Mar 19, 2020 – “Entos Pharmaceuticals has unveiled plans to develop a Fusogenix DNA vaccine for the prevention of COVID-19 infections….Upon completion of the development of the Fusogenix DNA vaccine formulation, the company will begin preclinical testing for safety and efficiency….The company will also work…for the advancement of novel Fusogenix vaccine to human clinical trials.”

 

Stabilitech’s Covid-19 vaccine for oral administration as a revolutionary thermally stable capsule (PRNewswire) – Mar 19, 2020 – “Stabilitech BioPharma…announced the development of a prototype COVID-19 starting viral stock which it intends to manufacture and administer orally in the form of patented capsules….Once approved by regulatory authorities, the Stabilitech vaccine will shake up the market thanks to its safe and effective self-administered capsules….The Company is currently in talks with a range of investors to finance its assets under development and benefits from the EIS Advance Assurance guarantee from the British tax authorities (HMRC).”

 

leronlimab (PRO 140) / CytoDyn, Vyera Pharma
U.S. Food and Drug Administration (FDA) grants emergency IND for two coronavirus patients treated in New York with CytoDyn’s leronlimab (GlobeNewswire) – Mar 19, 2020 – “CytoDyn Inc…announced today that two coronavirus patients were treated with the Company’s investigational new drug, leronlimab. The treatment was administered at a leading medical center in the New York City area under an emergency Investigational New Drug (IND) recently granted by the U.S. Food and Drug Administration (FDA). Leronlimab is intended to serve as a therapy for patients who experience respiratory illness as a result of contracting the Coronavirus Disease 2019 (COVID-19).”
IND

Mateon partners with Meridian IT to fast track drug manufacturing using artificial intelligence for coronaviruses, including COVID-19 (GlobeNewswire, Mateon Therapeutics) – Mar 19, 2020 – “Mateon intends to leverage on the AI machine vision technology used in the retail use cases to pharmaceutical manufacturing, especially with our lead product OT-101, which we are testing for coronaviruses, including the current COVID-19.”

 

Japanese researchers to take a look at blood thinner for coronavirus treatment (Gotech Daily) – Mar 19, 2020 – “A blood thinner…has been recognized as a probable treatment for COVID-19 individuals, with clinical trials in Japan possibly established to begin within a thirty day period, scientists at the College of Tokyo mentioned Wednesday….The drug, recognised by the scientific name nafamostat….The team located the drug’s probable potential by an experiment simulating the coronavirus’s an infection of human cells.”

 

ifenprodil (NP-120) / Algernon Pharma
Algernon to support planned phase 2 trial of ifenprodil for coronavirus (GlobeNewswire, Algernon Pharmaceuticals) – Mar 19, 2020 – “Algernon Pharmaceuticals…is pleased to announce that Novotech…has identified physicians in South Korea who have agreed to conduct an investigator initiated phase 2 clinical trial of Ifenprodil for coronavirus patients….Novotech was asked to advise on the most efficient regulatory approach to initiating a phase 2 clinical trial for Ifenprodil for COVID-19….The study approval process may be expedited due to the current global health crisis.”

 

The updates on Covid-19 in Korea as of 19 March (KCDC) – Mar 19, 2020 – “The KNIH is currently conducting a study of clinical epidemiology and immunology of COVID-19 patients and hopes that its findings will inform infection prevention policies.” ”

 

Stabilitech’s COVID-19 vaccine intended to be delivered in a disruptive thermally stable oral capsule (PRNewswire) – Mar 19, 2020 – “Stabilitech BioPharma Ltd…this morning announces the completion of its COVID-19 Master Viral Seedstock, which it now intends to have manufactured and formulated into its patent protected capsule for oral vaccine delivery. Once approved by the regulatory authorities, Stabilitech will disrupt the vaccine market by producing safe, efficacious, self-administered vaccine capsules that are inexpensive to produce, developed in weeks, thermally stable and can be posted direct to consumer.”

 

Coronavirus Vaccine / EpiVax, Generex
Generex Biotechnology provides guidance on the safety of Ii-key peptide vaccines for the development of effective solutions to the SARS-CoV-2 coronavirus pandemic (GlobeNewswire, Generex Biotechnology Corporation) – Mar 19, 2020 – “Generex Biotechnology Corporation…today provided guidance on their work to develop a peptide vaccine against the new coronavirus SARS-CoV-2 using the company’s proprietary and patented Ii-Key immune system activation technology. This guidance is designed to assist third party groups and government agencies in their evaluation of potential vaccines against this pandemic SARS-CoV-2 virus. The patented NuGenerex Immuno-Oncology (Formerly Antigen Express) Ii-Key technology uses synthetic peptides that mimic essential protein regions from a virus that are chemically linked to the 4-amino acid Ii-Key to ensure robust immune system activation.”

 

Phathom reports fourth quarter and full year 2019 financial results and provides clinical trial status and business updates (GlobeNewswire, Phathom Pharmaceuticals) – Mar 19, 2020 – “Due to the COVID-19 global pandemic, the Company is temporarily pausing new patient randomization in its PHALCON-EE and PHALCON-HP clinical trials….The temporary pause on new patient randomization aligns with the American Society for Gastrointestinal Endoscopy’s guidance on limiting endoscopies, which are required in both clinical trials, due to the COVID-19 pandemic and supports various governments’ restrictions on travel.”

Read More …
« Older Entries